The oral opiate antagonist naltrexone is in regular use in clinical practice with abstinent opiate-dependent individuals. Acute opioid withdrawal is a well-recognised consequence of consuming naltrexone while opiate dependent. Two cases of naltrexone-induced opiate withdrawal are reported. The compressed nature of the withdrawal syndrome in both of these cases and the implications for the management of protracted withdrawal symptoms are discussed. The theoretical implications of this experimental and clinical phenomenon are reviewed.
Blachley P.H. (1973) Naloxone for diagnosis in methadone programmes . J Am Med Assoc244: 334-335
2.
Blachley P.H., Casey D., Marcel L.J., Denney D.D. (1975) A model for study of the treatment of the opiate abstinence syndrome. In Senay E C (ed.), Developments in the field of drug abuse. Schenkman, Cambridge, MA, pp. 327-335
3.
Brewer C. (1993) Naltrexone in the prevention of relapse and opiate detoxification. In Brewer C (ed), Treatment options in addiction: medical management of alcohol and opiate abuse . Gaskell Publications, London, pp. 54-62
4.
Charney D.S., Heninger G.R., Kleber H.D. (1986) The combined use of clonidine and naltrexone as a rapid safe and effective treatment of abrupt withdrawal from methadone. Am Psychiatr143: 831-837
5.
Collier H O J (1968) Supersensitivity and dependence. Nature220: 228-231
6.
Dollery C. (1991) Therapeutic drugs, Vol. 2. Churchill, Edinburgh
7.
Farrell M. (1994) Opiate withdrawal. In West R, Gossop M (eds), Comparing drugs of dependence. Vol. 89. Addiction, pp.1471-1476
8.
Gonzalez J.P., Brogden R.N. (1988) Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence drugs. Drugs35:192-213
9.
Gossop M., Bradley B., Phillips G.T. (1987) An investigation of withdrawal symptoms shown by opiate addicts during and subsequent to a 21 day in patient methadone detoxification procedure. Addictive Behav12:1-6
Jaffe J.H. (1985) Drug addiction and drug abuse. In Gilman A G, Goodman L S, Murad F (eds), The pharmacological basis of therapeutics. (7th Edn.) Macmillan , USA, pp. 522-573
12.
Jaffe J.H., Sharples S.K. (1968) Pharmacological denervation supersensitivity in central nervous system; a theory of physical dependence. In Wikler A (ed.), The addictive states: research publications of the association for research in nervous and mental disease ,Vol. 46,Williams and Wilkins , Baltimore, MD, pp. 226-243
13.
Kirby K.C., Stitzer M.L., Heishman S.J. (1990) Accute opioid physical dependence in humans: effect of varying the morphine-naloxone interval. II. J Pharmacol Exp Ther255: 730-737
14.
Kleber H.D., Topazian M., Gaspari J., Riordan C.E., Kostent, et al. (1987) Clonidine and naltrexone in the out-patient treatment of heroin withdrawal . Am J Drug Alcohol Abuse13:1-17
15.
Loimer N., Schmid R., Resslich O., Lenz K. ( 1989) Continuous naloxone administration suppresses opiate withdrawal symptoms in human opiate addicts during detoxification treatment. J Psychiatr Res23: 81-86
16.
Stitzer M.L., Wright C., Bigelow G.E., June H.L., Felch L.J. (1991) Time course of naloxone-precipitated withdrawal after acute methadone exposure in humans. Drug Alcohol Depend29: 39-46
17.
Tornabene V.W. (1974) Narcotic withdrawal syndrome caused by naltrexone . Ann Intern Med81: 785-787
18.
Volavka J., Resnick R.B. (1976) Treatment of accidental naltrexone-induced withdrawal . Am J Psychiatr133: 233
19.
Wikler A. (1980) Opioid dependence: mechanisms and treatment. Plenum Press, New York
20.
Yoburn B.C., Inturrisi C.E. (1988) Modification of the response to opioid and non-opioid drugs by chronic opioids antagonist treatment. Life Sci32: 1689-1696
